Skip to contentA
Aethlon Medical Inc
A
AEMDAethlon Medical Inc Q2 2026 · 10-Q
Revenue—
Net Income-$1.49M-$1.49MN/M vs Q2 2025 EPS Diluted-$3.74-$3.74N/M vs Q2 2025 Operating Income-$1,509,830N/M Operating Cash Flowderived-$1,658,717N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aethlon Medical Inc · CIK 882291 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end